Alkermes (NASDAQ:ALKS) is one of the best beginner stocks to buy, according to analysts. On September 9, HC Wainwright reiterated a ‘Neutral’ rating on the stock and a $46 price target. The stance follows the company’s positive results from the Vibrance-1 phase 2 study. HC Wainwright Affirms Alkermes (ALKS) ‘Neutral’ Rating on Vibrance-1 Phase 2 Study Study results show that Alixorexton is the first orexin 2 receptor agonist to demonstrate a clinically meaningful and statistically significant impact on w ...